Carl‐Henrik Shah

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Gábor Liposits, Henrik Eshøj, Sören Möller et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Gábor Liposits, Halla Skúladóttir, Jesper Ryg et al. · Journal of Clinical Medicine · 2022 · 15 citations · Full text

Medicine, Immunology, Oncology +17

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Karin Holmsten, Line Dohn, Niels Viggo Jensen et al. · Oncology Letters · 2016 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

Melphalan‐flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma

Kristina Viktorsson, Carl‐Henrik Shah, Therese Juntti et al. · Molecular Oncology · 2016 · 12 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

Gábor Liposits, Jesper Ryg, Halla Skúladóttir et al. · Journal of Geriatric Oncology · 2022 · 12 citations · Full text

Medicine, Geriatric Medicine, Oncology +17